The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Nanoparticles in cancer therapy and diagnosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Protein—surface interactions in the presence of polyethylene oxide
Jeon, S. I., Lee, J. H., Andrade, J. D., & De Gennes, P. G. (1991) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(91)90043-8 · Cited by 1,523
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,378
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
Long circulating microparticulate drug carriers
Stolnik, S., Illum, L., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00025-3 · Cited by 700
Mitra, S., Gaur, U., Ghosh, P. C., & Maitra, A. N. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00342-x · Cited by 647
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635
Protein—surface interactions in the presence of polyethylene oxide
Jeon, S. I., & Andrade, J. D. (1991) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(91)90044-9 · Cited by 589
Design of Folic Acid‐Conjugated Nanoparticles for Drug Targeting
Stella, B., Arpicco, S., Peracchia, M. T., Desmaële, D., Hoebeke, J., Renoir, M., D'Angelo, J., Cattel, L., & Couvreur, P. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1452::aid-jps8>3.0.co;2-p · Cited by 553
Self-citationSignificant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
Which polymers can make nanoparticulate drug carriers long-circulating?
Torchilin, V. P., & Trubetskoy, V. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00022-y · Cited by 480
Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin–PLGA conjugates
Yoo, H. S., Lee, K. H., Oh, J. E., & Park, T. G. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00280-7 · Cited by 374
Bonnemain, B. (1998) · Journal of Drug Targeting · doi:10.3109/10611869808997890 · Cited by 371
Resistance mechanisms associated with altered intracellular distribution of anticancer agents
Larsen, A. K., Escargueil, A. E., & Skladanowski, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00073-x · Cited by 369
Tumoral Distribution of Long-circulating Dextran-coated Iron Oxide Nanoparticles in a Rodent Model
Moore, A., Marecos, E., Bogdanov, A., & Weissleder, R. (2000) · Radiology · doi:10.1148/radiology.214.2.r00fe19568 · Cited by 343
Passive tumor targeting of soluble macromolecules and drug conjugates.
Seymour, L. W. (1992) · PubMed · Cited by 316
Pharmacokinetics and distribution of a biodegradable drug-carrier
Grislain, L., Couvreur, P., Lenaerts, V., Roland, M., Deprez-Decampeneere, D., & Speiser, P. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90166-7 · Cited by 305
Self-citationJain, R. K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00306-6 · Cited by 298
Emilienne Soma, C., Dubernet, C., Bentolila, D., Benita, S., & Couvreur, P. (2000) · Biomaterials · doi:10.1016/s0142-9612(99)00125-8 · Cited by 281
Self-citationTanaka, K., Iwakuma, T., Harimaya, K., Sato, H., & Iwamoto, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119152 · Cited by 277
Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages
Moore, A., Weissleder, R., & Bogdanov, A. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070629 · Cited by 260
Improvement of MRI Probes To Allow Efficient Detection of Gene Expression
Högemann, D., Josephson, L., Weissleder, R., & Basilion, J. P. (2000) · Bioconjugate Chemistry · doi:10.1021/bc000079x · Cited by 259
Enochs, W. S., Harsh, G., Hochberg, F., & Weissleder, R. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199902)9:2<228::aid-jmri12>3.0.co;2-k · Cited by 253
Control of tumour vascular permeability
Baban, D. F., & Seymour, L. W. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00003-9 · Cited by 237
Lymphatic targeting with nanoparticulate system
Nishioka, Y., & Yoshino, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00121-6 · Cited by 223
Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded Nanoparticles
Couvreur, P., Kante, B., Grislain, L., Roland, M., & Speiser, P. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710717 · Cited by 217
Self-citationSelective Delivery of Adiramycin to a Solid Tumor Using a Polymeric Micelle Carrier System
Yokoyama, M., Okano, T., Sakurai, Y., Fukushima, S., Okamoto, K., & Kataoka, K. (1999) · Journal of Drug Targeting · doi:10.3109/10611869909085500 · Cited by 213
Angiostatin suppresses malignant glioma growth in vivo.
Kirsch, M., Strasser, J., Allende, R., Bello, L., Zhang, J., & Black, P. M. (1998) · PubMed · Cited by 185
Hawley, A. E., Davis, S. S., & Illum, L. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00045-9 · Cited by 183
Lambert, G., Fattal, E., Pinto-Alphandary, H., Gulik, A., & Couvreur, P. (2000) · Pharmaceutical Research · doi:10.1023/a:1007582332491 · Cited by 176
Self-citationde Verdière, A., Dubernet, C., Némati, F., Soma, E., Appel, M., Ferté, J., Bernard, S., Puisieux, F., & Couvreur, P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.362 · Cited by 168
Self-citationTiefenauer, L., Kuehne, G., & Andres, R. Y. (1993) · Bioconjugate Chemistry · doi:10.1021/bc00023a007 · Cited by 159
Unezaki, S., Maruyama, K., Hosoda, J.-I., Nagae, I., Koyanagi, Y., Nakata, M., Ishida, O., Iwatsuru, M., & Tsuchiya, S. (1996) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04674-1 · Cited by 158
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance
Cuvier, C., Roblot-Treupel, L., Millot, J. M., Lizard, G., Chevillard, S., Manfait, M., Couvreur, P., & Poupon, M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90443-m · Cited by 156
Self-citationKattan, J. G., Droz, J., Couvreur, P., Marino, J. P., Boutan-Laroze, A., Rougier, P. R., Brault, P., Vranckx, H., Grognet, J., Morge, X., et al. (1992) · Investigational New Drugs · doi:10.1007/bf00877245 · Cited by 153
Self-citationDaemen, T., Hofstede, G., ten Kate, M. T., Bakker‐Woudenberg, I. A. J. M., & Scherphof, G. L. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610520 · Cited by 153
Tissue Distribution of Antitumor Drugs Associated with Polyalkylcyanoacrylate Nanoparticles
Couvreur, P., Kante, B., Lenaerts, V., Scailteur, V., Roland, M., & Speiser, P. P. (1980) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600690222 · Cited by 152
Self-citationJuliano, R. L., Alahari, S. K., Yoo, H., Kole, R., & Cho, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1011958726518 · Cited by 145
Bennis, S., Chapey, C., Robert, J., & Couvreur, P. (1994) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80025-5 · Cited by 142
Self-citationPeracchia, M. T., Vauthier, C., Desmaële, D., Gulik, A., Dedieu, J., Demoy, M., d’Angelo, J., & Couvreur, P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011973625803 · Cited by 141
Self-citationTokumitsu, H., Hiratsuka, J., Sakurai, Y., Kobayashi, T., Ichikawa, H., & Fukumori, Y. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00388-2 · Cited by 140
In vitro model for the degradation of alkylcyanoacrylate nanoparticles
Müller, R. H., Lherm, C., Herbert, J., & Couvreur, P. (1990) · Biomaterials · doi:10.1016/0142-9612(90)90084-4 · Cited by 138
Self-citationTransvascular drug delivery in solid tumors
Fan, Y. (1998) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(98)80042-8 · Cited by 132
Chiannilkulchai, N., Ammoury, N., Caillou, B., Devissaguet, J. P., & Couvreur, P. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf02897257 · Cited by 130
Self-citationBiodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides
Fattal, E., Vauthier, C., Aynié, I., Nakada, Y., Lambert, G., Malvy, C., & Couvreur, P. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00246-0 · Cited by 129
Self-citationMR imaging of phagocytosis in experimental gliomas.
Zimmer, C., Weissleder, R., Poss, K., Bogdanova, A., Wright, S. C., & Enochs, W. S. (1995) · Radiology · doi:10.1148/radiology.197.2.7480707 · Cited by 121
MR lymphography: study of a high-efficiency lymphotrophic agent.
Weissleder, R., Heautot, J. F., Schaffer, B., Nossiff, N. D., Papisov, M. I., Bogdanov, A. A., Jr., & Brady, T. J. (1994) · Radiology · doi:10.1148/radiology.191.1.8134576 · Cited by 120
Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells
de Verdière, A. C., Dubernet, C., Némati, F., Poupon, M., Puisieux, F., & Couvreur, P. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686509 · Cited by 119
Self-citationEWS Fli-1 Antisense Nanocapsules Inhibits Ewing Sarcoma-Related Tumor in Mice
Lambert, G., Bertrand, J. R., Fattal, E., Subra, F., Pinto‐Alphandary, H., Malvy, C., Auclair, C., & Couvreur, P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3963 · Cited by 118
Self-citationTissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles
Verdun, C., Brasseur, F., Vranckx, H., Couvreur, P., & Roland, M. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf02940287 · Cited by 115
Self-citationAynié, I., Vauthier, C., Chacun, H., Fattal, E., & Couvreur, P. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.301 · Cited by 114
Self-citationDoxorubicin-Loaded Nanoparticles: Increased Efficiency in Murine Hepatic Metastases
Chiannilkulchai, N., Driouich, Z., Benoît, J., PARODI, A. L., & Couvreur, P. (1989) · Selective Cancer Therapeutics · doi:10.1089/sct.1989.5.1 · Cited by 102
Self-citationPolymeric nanoparticles and microspheres
Banakar, U. V. (1988) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600770123 · Cited by 99
Allémann, É., Rousseau, J. A., Brasseur, N., Kudrevich, S. V., Lewis, K., & van Lier, J. E. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960611)66:6<821::aid-ijc19>3.0.co;2-5 · Cited by 96
Increased bone marrow toxicity of doxorubicin bound to nanoparticles
Gibaud, S., Andreux, J. P., Weingarten, C., et al. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90299-2 · Cited by 89
Soma, C. E., Dubernet, C., BARRATT, G. M., Benita, S., & Couvreur, P. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00269-8 · Cited by 86
Self-citationClinical relevance of the molecular mechanisms of resistance to anti-cancer drugs
Brown, R. E., & Links, M. J. (1999) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399499001099x · Cited by 85
Peracchia, M. T., Vauthier, C., Puisieux, F., & Couvreur, P. (1997) · Journal of Biomedical Materials Research · Cited by 84
Self-citationPEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers
Li, Y., Pei, Y., Zhou, Z.-H., Zhang, X., Gu, Z.-H., Ding, J., Zhou, J.-J., & Gao, X.-J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00235-8 · Cited by 76
Reszka, R. C., Beck, P., Fichtner, I., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36380-3 · Cited by 56
Lode, J., Fichtner, I., Kreuter, J., Berndt, A., Diederichs, J. E., & Reszka, R. C. (2001) · Pharmaceutical Research · doi:10.1023/a:1013094801351 · Cited by 47
Pepin, X. J. H., Attali, L., Domrault, C., Gallet, S., Métreau, J. M., Reault, Y., Cardot, P. J. P., Imalalen, M., Dubernet, C., Soma, C. E., et al. (1997) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00362-9 · Cited by 38
Self-citationRolland, A. P. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90330-x · Cited by 36
Kubiak, C., Couvreur, P., Manil, L., et al. (1989) · Biomaterials · doi:10.1016/0142-9612(89)90062-8 · Cited by 31
Self-citationLabelled polycyanoacrylate nanoparticles for human In Vivo use
Ghanem, G. E., Joubran, C., Arnould, R., Lejeune, F., & Frühling, J. G. (1993) · Applied Radiation and Isotopes · doi:10.1016/0969-8043(93)90068-l · Cited by 23
Research works printed but not linked: 23
- Krishna, 2000, Multidrug resistance (MDR) in cancer—mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs, Eur. J. Cancer Sci., 11, 265
- Brasseur, 1980, Actinomycin D adsorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor, Eur. J. Cancer, 10, 1441, 10.1016/0014-2964(80)90053-5 · doi:10.1016/0014-2964(80)90053-5
- Manil, 1995, Acute renal toxicity of doxorubicin (adriamycin)-loaded cyanoacrylate nanoparticles, Pharm. Res., 12, 85, 10.1023/A:1016290704772 · doi:10.1023/a:1016290704772
- Blagoeva, 1992, Diminished genotoxicity of mitomycin C and farmorubicin included in polybutylcyanoacrylate nanoparticles, Mutat. Res., 268, 77, 10.1016/0027-5107(92)90085-G · doi:10.1016/0027-5107(92)90085-g
- Sharma, 1996, Novel taxol® formulation: polyvinylpyrrolidone nanoparticles-encapsulated taxol® for drug delivery in cancer therapy, Oncol. Res., 8, 281
- Sakakura, 1992, Enhancement of therapeutic efficacy of aclarubicin against lymph node metastases using a new dosage form: aclarubicin adsorbed on activated carbon particles, Anti-Cancer Drugs, 3, 233, 10.1097/00001813-199206000-00005 · doi:10.1097/00001813-199206000-00005
- Hagiwara, 1997, Selective drug delivery to peri-tumoral region and regional lymphatics by local injection of aclarubicin adsorbed on activated carbon particles in patients with breast cancer—a pilot study, Anti-Cancer Drugs, 8, 666, 10.1097/00001813-199708000-00004 · doi:10.1097/00001813-199708000-00004
- Schwab, 1994, Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice, Proc. Natl. Acad. Sci. USA, 91, 10460, 10.1073/pnas.91.22.10460 · doi:10.1073/pnas.91.22.10460
- Chavany, 1994, Adsorption of oligonucleotides onto poly(isohexylcyanoacrylate) nanoparticles protects them against nucleases and increases their cellular uptake, Pharm. Res., 11, 1370, 10.1023/A:1018923301967 · doi:10.1023/a:1018923301967
- Godard, 1995, Antisense effect of cholesterol–oligodeoxynucleotide conjugates associated with poly(alkylcyanoacrylate) nanoparticles, Eur. J. Biochem., 232, 404, 10.1111/j.1432-1033.1995.tb20825.x · doi:10.1111/j.1432-1033.1995.tb20825.x
- Tondelli, 1998, Highly efficient cellular uptake of c-myb antisense oligonucleotides through specifically designed polymeric nanospheres, Nucleic Acids Res., 26, 5425, 10.1093/nar/26.23.5425 · doi:10.1093/nar/26.23.5425
- Zimmer, 1999, Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers, Methods: A Companion to Methods in Enzymology, 18, 286, 10.1006/meth.1999.0786 · doi:10.1006/meth.1999.0786
- Ganachaud, 1997, Adsorption of single-strand DNA fragments onto cationic aminated latex particles, Langmuir, 13, 701, 10.1021/la960896e · doi:10.1021/la960896e
- Hu, 1996, On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistance, Cancer Chemother. Pharmacol., 37, 556, 10.1007/s002800050428 · doi:10.1007/s002800050428
- Astier, 1988, Enhancement of adriamycin antitumor activity by its binding with an intracellular sustained-release form, polymethacrylate nanospheres, in U-937 cells, Cancer Res., 48, 1835
- Nafziger, 1995, Synthesis and antiproliferative effects of a 4′-morpholino-9-methyl anthracycline, J. Antibiot., 48, 1185, 10.7164/antibiotics.48.1185 · doi:10.7164/antibiotics.48.1185
- Leo, 1997, General and cardiac toxicity of doxorubicin-loaded gelatin nanoparticles, Il Farmaco, 52, 385
- Bhalgat, 1998, Green- and red-fluorescent nanospheres for the detection of cell surface receptors by flow cytometry, J. Immunol. Methods, 219, 57, 10.1016/S0022-1759(98)00121-5 · doi:10.1016/s0022-1759(98)00121-5
- Väisänen, 2000, Time-resolved fluorescence imaging for quantitative histochemistry using lanthanide chelates in nanoparticles and conjugated to monoclonal antibodies, Luminescence, 15, 389, 10.1002/1522-7243(200011/12)15:6<389::AID-BIO626>3.0.CO;2-7 · doi:10.1002/1522-7243(200011/12)15:6<389::aid-bio626>3.0.co;2-7
- Santra, 2001, Development of novel dye-doped silica nanoparticles for biomarker application, J. Biomed. Opt., 6, 160, 10.1117/1.1353590 · doi:10.1117/1.1353590
- Wisner, 1996, Indirected computed tomography lymphography using iodinated nanoparticles to detect cancerous lymph nodes in a cutaneous melanoma model, Acad. Radiol., 3, 40, 10.1016/S1076-6332(96)80331-X · doi:10.1016/s1076-6332(96)80331-x
- Wisner, 1996, Characterization of normal and cancerous lymph nodes on indirect computed tomography lymphographic studies after interstitial injection of iodinated nanoparticles, Acad. Radiol., 3, S257, 10.1016/S1076-6332(96)80551-4 · doi:10.1016/s1076-6332(96)80551-4
- Clément, 1994, Magnetic resonance lymphography—Enhancement patterns using superparamagnetic nanoparticles, Invest. Radiol., 29, S226, 10.1097/00004424-199406001-00075 · doi:10.1097/00004424-199406001-00075
Cited by
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Synthesis, characterization, applications, and challenges of iron oxide nanoparticles
Ali, A., Zafar, H., Zia, M., ul Haq, I., Phull, A. R., Ali, J. S., & Hussain, A. (2016) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s99986 · Cited by 1,591
Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery
Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273
Therapeutic targeting of microRNAs: current status and future challenges
Li, Z., & Rana, T. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4359 · Cited by 1,033
Advances in Biomaterials for Drug Delivery
Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 855
Metadata
- Authors
- Brigger, I., Dubernet, C., & Couvreur, P.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 64
- Pages
- 24-36
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4232680877
- Cited by
- 956
- References
- 72
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.